Skip to main navigation Skip to search Skip to main content

COVID-19 in pediatric kidney transplantation: a follow-up report of the Improving Renal Outcomes Collaborative

  • Charles Varnell
  • , Lyndsay A. Harshman
  • , Chunyan Liu
  • , Laurie Smith
  • , Samhar Al-Akash
  • , Gina Marie Barletta
  • , Paul Brakeman
  • , Abanti Chaudhuri
  • , Paul Fadakar
  • , Lauren Galea
  • , Rouba Garro
  • , Caroline Gluck
  • , David B. Kershaw
  • , Debora Matossian
  • , Hiren P. Patel
  • , Caitlin Peterson
  • , Cozumel Pruette
  • , Saritha Ranabothu
  • , Nancy Rodig
  • , Pamela Singer
  • Judith Sebestyen VanSickle, Patricia L. Weng, Lara Danziger-Isakov, Michael E. Seifert, David K. Hooper
  • Cincinnati Children's Hospital Medical Center
  • University of Cincinnati
  • University of Iowa
  • Driscoll Children’s Hospital
  • University of Arizona
  • University of California at San Francisco
  • Stanford University
  • University of Pittsburgh
  • The Children's Hospital of Philadelphia
  • Children's Healthcare of Atlanta
  • Alfred I. duPont Hospital for Children
  • University of Michigan, Ann Arbor
  • Children's Memorial Hospital
  • Nationwide Children’s Hospital
  • University of Utah
  • Johns Hopkins University
  • University of Arkansas for Medical Sciences
  • Harvard University
  • Hofstra North Shore-LIJ School of Medicine
  • Children's Mercy Hospitals and Clinics
  • University of California at Los Angeles
  • University of Alabama at Birmingham

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Background: We report follow-up data from an ongoing prospective cohort study of COVID-19 in pediatric kidney transplantation through the Improving Renal Outcomes Collaborative (IROC). Methods: Patient-level data from the IROC registry were combined with testing, indication, and outcomes data collected to describe the epidemiology of COVID testing, treatment, and clinical outcomes; determine the incidence of a positive COVID-19 test; describe rates of COVID-19 testing; and assess for clinical predictors of a positive COVID-19 test. Results: From September 2020 to February 2021, 21 centers that care for 2690 patients submitted data from 648 COVID-19 tests on 465 patients. Most patients required supportive care only and were treated as outpatients, 16% experienced inpatient care, and 5% experienced intensive care. Allograft complications were rare, with acute kidney injury most common (7%). There was 1 case of respiratory failure and 1 death attributed to COVID-19. Twelve centers that care for 1730 patients submitted complete testing data on 351 patients. The incidence of COVID-19 among patients at these centers was 4%, whereas the incidence among tested patients was 19%. Risk factors to predict a positive COVID-19 test included age > 12 years, symptoms consistent with COVID-19, and close contact with a confirmed case of COVID-19. Conclusions: Despite the increase in testing and positive tests over this study period, the incidence of allograft loss or death related to COVID-19 remained extremely low, with allograft loss or death each occurring in < 1% of COVID-19-positive patients and in less than < 0.1% of all transplant patients within the IROC cohort. Graphical abstract: A higher resolution version of the Graphical abstract is available as Supplementary information [Figure not available: see fulltext.].

Original languageEnglish
Pages (from-to)537-547
Number of pages11
JournalPediatric Nephrology
Volume38
Issue number2
DOIs
StatePublished - Feb 2023
Externally publishedYes

Keywords

  • COVID-19
  • COVID-19 Testing
  • Child
  • Follow-Up Studies
  • Humans
  • Kidney Transplantation/adverse effects
  • Prospective Studies

Fingerprint

Dive into the research topics of 'COVID-19 in pediatric kidney transplantation: a follow-up report of the Improving Renal Outcomes Collaborative'. Together they form a unique fingerprint.

Cite this